What Makes Us Unique!
Beginning in 1999, BHSPC was chosen as a Community Treatment Program (CTP) within the Southern Consortium Node (SC Node) of the nationwide Clinical Trials Network (CTN). The Medical University of South Carolina (MUSC) leads the SC Node and is comprised of five research CTPs. The CTN is an initiative by the National Institute on Drug Abuse whose mission is to improve the quality of drug abuse treatment throughout the country using science as the vehicle.
BHSPC is honored to be a part of such a prestigious research group especially given the rural setting of Pickens County. The participants in our research studies are able to influence treatment options nationally, and we are grateful to them for sharing their experience-based knowledge with us. Not only do we acknowledge their support through our words, we also compensate them for their time which is valuable to us as we join together to help find new treatment methods.
The future of the research department is solely dependent on outside funding and the formulation of new research ideas. We are currently collaborating with MUSC on several innovative concepts. We are looking forward to research prospects that benefit our clients as well as the community.
“Smoking Cessation in Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs”, CTN -0009, 2000-2005
“The Use of Acamprosate in Alcohol Dependent Individuals with Comorbid Anxiety and Depressive Disorders”, 2006-2007
“A Two-Phase Randomized Controlled Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence”, CTN – 0030, 2007 – 2009
“Cue Extinction in Methamphetamine Using Individuals”, 2007- 2009
“Effects of Modafinil in Methamphetamine Dependence”, 2009- 2010
“Clinical Circuitry Underlying Methamphetamine Cue Craving and Cue Extinction”, 2009 – 2010
“D-cycloserine Facilitation of Cocaine-Cue Extinction”, 2010
“Smoking-Cessation and Stimulant Treatment,” CTN- 0046, 2010 – 2012
“Achieving Cannabis Cessation—Evaluating N-Acetylcysteine Treatment,” CTN- 0053, 2014-2015
“Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder,” CTN-0068, 2016-current